The usefulness of artificial cerebrospinal fluid in recurrence of chronic subdural hematoma

The usefulness of artificial cerebrospinal fluid in recurrence of chronic subdural hematoma - The usefulness of artificial cerebrospinal fluid in recurrence of chronic subdural hematoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000010359

Enrollment

100

Registered

2013-04-01

Start date

2013-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic subdural hematoma

Interventions

ARTCEREB normal saline

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with surgical treatment for chronic subdural hematoma

Exclusion criteria

Exclusion criteria: 1. Patients within 14 days after head injury 2. Patients previous received ipsilateral head surgery

Design outcomes

Primary

Measure	Time frame
Recurrence rate within 3 months after surgery	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026